Lymphatic and Systemic Immunity Changes in Post-radiation Lymphedema Development

NCT02949726 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Lymphedema

Interventions

DRUG: Indocyanine Green (ICG)
DEVICE: Near-infrared Fluorescence Lymphatic Imaging (NIRFLI)

Sponsor

The University of Texas Health Science Center, Houston

Collaborators

[object Object]
[object Object]